X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4748) 4748
Publication (370) 370
Book Review (77) 77
Book Chapter (58) 58
Newspaper Article (25) 25
Book / eBook (17) 17
Conference Proceeding (13) 13
Newsletter (8) 8
Magazine Article (5) 5
Dissertation (2) 2
Data Set (1) 1
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2535) 2535
index medicus (2047) 2047
animals (1896) 1896
iron (1693) 1693
male (1516) 1516
female (1067) 1067
iron - metabolism (1002) 1002
iron chelating agents - therapeutic use (884) 884
rats (838) 838
oxidative stress (701) 701
biochemistry & molecular biology (654) 654
adult (626) 626
hematology (625) 625
iron chelating agents - pharmacology (623) 623
deferoxamine (605) 605
pharmacology & pharmacy (599) 599
iron chelating agents - administration & dosage (578) 578
mice (561) 561
iron overload (495) 495
iron overload - drug therapy (454) 454
deferoxamine - therapeutic use (441) 441
deferiprone (426) 426
adolescent (400) 400
child (384) 384
thalassemia (373) 373
desferrioxamine (368) 368
middle aged (338) 338
ferritin (330) 330
analysis (329) 329
beta-thalassemia (329) 329
metabolism (329) 329
antioxidants (326) 326
deferasirox (320) 320
chelation (319) 319
chelation therapy (317) 317
deferoxamine - pharmacology (316) 316
oncology (311) 311
administration, oral (310) 310
deferoxamine - administration & dosage (303) 303
overload (303) 303
toxicity (302) 302
therapy (295) 295
liver - metabolism (286) 286
ferritins - blood (283) 283
iron - blood (281) 281
health aspects (279) 279
cancer (277) 277
toxicology (276) 276
pyridones - therapeutic use (275) 275
iron chelating agents - adverse effects (273) 273
iron overload - etiology (270) 270
neurosciences (270) 270
research (264) 264
dose-response relationship, drug (261) 261
liver (261) 261
care and treatment (247) 247
transfusion reaction (244) 244
iron chelation (243) 243
free radicals (241) 241
magnetic resonance imaging (240) 240
chelating agents (237) 237
rats, wistar (234) 234
proteins (233) 233
treatment outcome (233) 233
lipid-peroxidation (232) 232
anemia (231) 231
antioxidants - pharmacology (228) 228
benzoates - therapeutic use (228) 228
blood transfusion (228) 228
triazoles - therapeutic use (227) 227
article (226) 226
copper (226) 226
beta-thalassemia - drug therapy (218) 218
in-vitro (217) 217
oxidative stress - drug effects (215) 215
rats, sprague-dawley (211) 211
nanoparticles (207) 207
physiological aspects (203) 203
disease models, animal (202) 202
chelating agents - pharmacology (201) 201
medicine (201) 201
time factors (199) 199
endocrinology & metabolism (198) 198
iron chelators (198) 198
in-vivo (196) 196
aged (195) 195
cell biology (195) 195
iron chelating agents - chemistry (193) 193
child, preschool (192) 192
pyridones - administration & dosage (192) 192
apoptosis (191) 191
disease (184) 184
medicine & public health (183) 183
thalassemia major (182) 182
medicine, research & experimental (180) 180
benzoates - administration & dosage (179) 179
zinc (179) 179
iron compounds (177) 177
triazoles - administration & dosage (177) 177
cells (173) 173
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4780) 4780
French (19) 19
German (15) 15
Japanese (14) 14
Russian (8) 8
Italian (6) 6
Spanish (6) 6
Portuguese (4) 4
Chinese (3) 3
Czech (2) 2
Dutch (2) 2
Korean (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 08/2017, Volume 134, Issue 4, pp. 203 - 210
Journal Article
Antioxidants & Redox Signaling, ISSN 1523-0864, 07/2014, Volume 21, Issue 2, pp. 195 - 210
Journal Article
Blood, ISSN 0006-4971, 03/2014, Volume 123, Issue 10, pp. 1447 - 1454
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 04/2007, Volume 115, Issue 14, pp. 1876 - 1884
Background - Cardiac complications secondary to iron overload are the leading cause of death in beta-thalassemia major. Approximately two thirds of patients... 
Heart failure | Trials | Magnetic resonance imaging | Thalassemia | Deferiprone | Deferoxamine | Endothelium | OVERLOAD | SURVIVAL | endothelium | heart failure | DIAGNOSIS | magnetic resonance imaging | CARDIAC & CARDIOVASCULAR SYSTEMS | thalassemia | TREATED PATIENTS | DESFERRIOXAMINE | ENDOTHELIAL FUNCTION | deferiprone | deferoxamine | trials | CHELATION-THERAPY | TRANSFUSION | DISEASE | PERIPHERAL VASCULAR DISEASE | BETA-THALASSEMIA | HEMATOLOGY | Iron Overload - drug therapy | Myocardium - chemistry | Agranulocytosis - chemically induced | Humans | Deferoxamine - therapeutic use | Male | Chelation Therapy | beta-Thalassemia - complications | Deferoxamine - administration & dosage | Deferoxamine - adverse effects | Arthralgia - chemically induced | Heart Failure - prevention & control | Iron - analysis | Iron Overload - etiology | Pyridones - administration & dosage | Ferritins - blood | Adult | Female | Iron Chelating Agents - administration & dosage | Drug Therapy, Combination | Neutropenia - chemically induced | Iron Chelating Agents - therapeutic use | Double-Blind Method | Magnetic Resonance Spectroscopy | Endothelium, Vascular - physiopathology | Liver - chemistry | Iron Chelating Agents - adverse effects | Stroke Volume | beta-Thalassemia - drug therapy | Pyridones - therapeutic use | Gastrointestinal Diseases - chemically induced | Pyridones - adverse effects | Usage | Patient outcomes | Research | Health aspects
Journal Article